Agios Pharmaceuticals (AGIO) Stock Forecast & Price Target

$41.23 +2.26 (+5.80%)

(As of 11:21 AM ET)

Agios Pharmaceuticals - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy

Based on 8 Analyst Ratings

Sell
0

Hold
4

Buy
4

Based on 8 Wall Street analysts who have issued ratings for Agios Pharmaceuticals in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 8 analysts, 4 have given a hold rating, and 4 have given a buy rating for AGIO.

Consensus Price Target

$56.33
36.63% Upside

According to the 8 analysts' twelve-month price targets for Agios Pharmaceuticals, the average price target is $56.33. The highest price target for AGIO is $75.00, while the lowest price target for AGIO is $46.00. The average price target represents a forecasted upside of 36.63% from the current price of $41.23.

Get the Latest News and Ratings for AGIO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Agios Pharmaceuticals and its competitors.

AGIO Analyst Ratings Over Time

Type	Current Forecast 12/17/23 to 12/16/24	1 Month Ago 11/17/23 to 11/16/24	3 Months Ago 9/18/23 to 9/17/24	1 Year Ago 12/17/22 to 12/17/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	2 Buy rating(s)	2 Buy rating(s)
Hold	4 Hold rating(s)	4 Hold rating(s)	2 Hold rating(s)	2 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$56.33	$52.33	$51.33	$35.20
Forecasted Upside	36.63% Upside	-2.69% Downside	12.35% Upside	51.46% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Is the Trump/Musk duo good for shares of TSLA? (Ad)

If you held shares of Tesla throughout 2024, you know It’s been a year of extreme highs and lows… But according to our one expert, new yearly highs are on the horizon… In his words, Tesla is building momentum like in 2020, especially as Trump supports the EV maker. Which is why we’re emailing you now… You see, most people will simply buy shares of Tesla ahead of the election… But as they say “There is more than one way to skin a cat” In fact, we’ve found another way to play shares of Tesla.

Discover how to trade Tesla, simply follow this link here.

AGIO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

AGIO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Agios Pharmaceuticals Stock vs. The Competition

Type	Agios Pharmaceuticals	Medical Companies	S&P 500
Consensus Rating Score	2.50	2.81	2.51
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy
Predicted Upside	44.56% Upside	29,826.32% Upside	10.64% Upside
News Sentiment Rating	Positive News See Recent AGIO News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/10/2024	Royal Bank of Canada 4 of 5 stars		Boost Target	Outperform ➝ Outperform	$55.00 ➝ $57.00	+15.90%
12/9/2024	Scotiabank 5 of 5 stars	G. Harrison Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Sector Outperform ➝ Sector Outperform	$53.00 ➝ $75.00	+44.40%
10/10/2024	Raymond James 4 of 5 stars	D. Brill Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform	$51.00	+24.39%
9/27/2024	Leerink Partnrs Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Berens Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
9/27/2024	Leerink Partners Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Outperform ➝ Market Perform	$60.00 ➝ $56.00	+16.55%
9/20/2024	Cantor Fitzgerald Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Overweight
Get the Latest News and Ratings for AGIO and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Agios Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.
6/13/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Neutral ➝ Neutral	$46.00	-1.65%
6/4/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Neutral ➝ Neutral	$33.00 ➝ $53.00	+15.49%
5/5/2023	SVB Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$37.00 ➝ $34.00	+30.57%
2/3/2023	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$41.00	+35.85%
2/3/2023	Piper Sandler Companies Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Overweight	$41.00	+35.85%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Monday at 11:50 AM ET.

AGIO Forecast - Frequently Asked Questions

: According to the research reports of 8 Wall Street equities research analysts, the average twelve-month stock price forecast for Agios Pharmaceuticals is $56.33, with a high forecast of $75.00 and a low forecast of $46.00.
: 8 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Agios Pharmaceuticals in the last twelve months. There are currently 4 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" AGIO shares.
: According to analysts, Agios Pharmaceuticals's stock has a predicted upside of 36.63% based on their 12-month stock forecasts.
: Over the previous 90 days, Agios Pharmaceuticals's stock had 2 downgrades by analysts.
: Agios Pharmaceuticals has been rated by research analysts at Cantor Fitzgerald, Leerink Partners, Leerink Partnrs, Raymond James, Royal Bank of Canada, and Scotiabank in the past 90 days.
: Analysts like Agios Pharmaceuticals less than other "medical" companies. The consensus rating score for Agios Pharmaceuticals is 2.50 while the average consensus rating score for "medical" companies is 2.81. Learn more on how AGIO compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Is the Trump/Musk duo good for shares of TSLA? (Ad)

Discover how to trade Tesla, simply follow this link here.

This page (NASDAQ:AGIO) was last updated on 12/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Agios Pharmaceuticals (AGIO) Stock Forecast & Price Target